"Designing Growth Strategies is in our DNA"
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4. Key Insights
4.1 Pipeline Analysis
4.2 Regulatory Scenario for Key Countries
4.3 Pricing Analysis
4.4 Key Industry Developments-Mergers, Acquisitions, and Partnerships
4.5 Incidence & Prevalence of Rheumatoid Arthritis, By Key Countries
4.6 Snapshot of The Novel & Upcoming Therapies
4.7 An Overview of Treatment Plans For Rheumatoid Arthritis
5. Global Rheumatoid Arthritis Therapeutics Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Product
5.2.1 Biologics
5.2.2 Non-Biologics
5.2.2.1 NSAIDs
5.2.2.2 DMARDs
5.2.2.3 Others
5.3. Market Analysis, Insights and Forecast – By Distribution Channel
5.3.1 Hospital Pharmacy
5.3.2 Retail Pharmacy
5.3.3 Online Pharmacy
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1 North America
5.4.2 Europe
5.4.3 Asia Pacific
5.4.4 Latin America
5.4.5 Middle East & Africa
6. North America Rheumatoid Arthritis Therapeutics Market Analysis, Insights and Forecast,2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis – By Product
6.2.1 Biologics
6.2.2 Non-Biologics
6.2.2.1 NSAIDs
6.2.2.2 DMARDs
6.2.2.3 Others
6.3. Market Analysis – By Distribution Channel
6.3.1 Hospital Pharmacy
6.3.2 Retail Pharmacy
6.3.3 Online Pharmacy
6.4. Market Analysis – By Country
6.4.1 U.S.
6.4.2 Canada
7. Europe Rheumatoid Arthritis Therapeutics Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis – By Product
7.2.1 Biologics
7.2.2 Non-Biologics
7.2.2.1 NSAIDs
7.2.2.2 DMARDs
7.2.2.3 Others
7.3. Market Analysis – By Distribution Channel
7.3.1 Hospital Pharmacy
7.3.2 Retail Pharmacy
7.3.3 Online Pharmacy
7.4. Market Analysis – By Country/Sub-region
7.4.1 U.K
7.4.2 Germany
7.4.3 France
7.4.4 Italy
7.4.5 Spain
7.4.6 Scandinavia
7.4.7 Rest of Europe
8. Asia Pacific Rheumatoid Arthritis Therapeutics Market Analysis, Insights and Forecast,2015-2026
8.1. Key Findings / Summary
8.2. Market Analysis – By Product
8.2.1 Biologics
8.2.2 Non-Biologics
8.2.2.1 NSAIDs
8.2.2.2 DMARDs
8.2.2.3 Others
8.3. Market Analysis – By Distribution Channel
8.3.1 Hospital Pharmacy
8.3.2 Retail Pharmacy
8.3.3 Online Pharmacy
8.4. Market Analysis – By Country/Sub-region
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 Southeast Asia
8.4.6 Rest of Asia Pacific
9. Latin America Rheumatoid Arthritis Therapeutics Market Analysis, Insights and Forecast,2015-2026
9.1. Key Findings / Summary
9.2. Market Analysis – By Product
9.2.1 Biologics
9.2.2 Non-Biologics
9.2.2.1 NSAIDs
9.2.2.2 DMARDs
9.2.2.3 Others
9.3. Market Analysis – By Distribution Channel
9.3.1 Hospital Pharmacy
9.3.2 Retail Pharmacy
9.3.3 Online Pharmacy
9.4. Market Analysis – By Country/Sub-region
9.4.1 Brazil
9.4.2 Mexico
9.4.3 Rest of Latin America
10. Middle East &Africa Rheumatoid Arthritis Therapeutics Market Analysis, Insights andForecast, 2015-2026
10.1. Key Findings / Summary
10.2. Market Analysis – By Product
10.2.1 Biologics
10.2.2 Non-Biologics
10.2.2.1 NSAIDs
10.2.2.2 DMARDs
10.2.2.3 Others
10.3. Market Analysis – By Distribution Channel
10.3.1 Hospital Pharmacy
10.3.2 Retail Pharmacy
10.3.3 Online Pharmacy
10.4. Market Analysis – By Country/Sub-region
10.4.1 GCC Countries
10.4.2 South Africa
10.4.3 Rest of Middle East & Africa
11. Competitive Analysis
11.1. Key Industry Developments
11.2. Global Market Share Analysis (2017)
11.3. Competition Dashboard
11.4. Comparative Analysis –Major Players
11.5. Company Profiles (Overview,Products & services, SWOT analysis, Recent developments, strategies,financials (based on availability))
11.5.1 AbbVieInc.
11.5.2 PfizerInc.
11.5.3 AmgenInc.
11.5.4 Johnson& Johnson Services, Inc.
11.5.5 CELGENE CORPORATION
11.5.6 Bristol-Myers Squibb Company
11.5.7 F.Hoffmann-La Roche AG
11.5.8 UCBS.A.
11.5.9 UCBS.A.
11.5.10 Gilead Sciences, Inc.
11.5.11 Other Prominent Market Players
12. Strategic Recommendations
Related Reports